Corient Capital Partners, LLC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,079 filers reported holding BAXTER INTL INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Corient Capital Partners, LLC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2022$1,151,0000.0%17,9260.0%0.09%
-1.1%
Q2 2022$1,151,000
-4.3%
17,926
+15.5%
0.09%
+10.1%
Q1 2022$1,203,000
-7.2%
15,517
+2.7%
0.08%
-8.1%
Q4 2021$1,297,000
-22.1%
15,109
-27.0%
0.09%
-29.5%
Q3 2021$1,665,000
+8.5%
20,707
+8.6%
0.12%
+8.9%
Q2 2021$1,534,000
+8.3%
19,062
+13.5%
0.11%
-7.4%
Q1 2021$1,417,000
-28.1%
16,799
-31.6%
0.12%
-38.6%
Q4 2020$1,970,000
-2.7%
24,551
-2.5%
0.20%
-15.5%
Q3 2020$2,025,000
-9.8%
25,179
-3.4%
0.23%
-15.0%
Q2 2020$2,244,000
+40.7%
26,064
+32.7%
0.27%
+9.2%
Q1 2020$1,595,000
+2.5%
19,646
+5.6%
0.25%
+26.8%
Q4 2019$1,556,000
-9.2%
18,608
-5.0%
0.20%
-18.5%
Q3 2019$1,713,000
+11.3%
19,593
+4.3%
0.24%
+3.0%
Q2 2019$1,539,000
+3.3%
18,782
+2.5%
0.24%
-2.5%
Q1 2019$1,490,000
+31.6%
18,319
+6.5%
0.24%
+19.8%
Q4 2018$1,132,000
-17.4%
17,204
-3.2%
0.20%
-11.4%
Q3 2018$1,371,000
+4.4%
17,7770.0%0.23%
-0.4%
Q2 2018$1,313,000
+15.1%
17,777
+1.4%
0.23%
+9.0%
Q1 2018$1,141,000
-51.0%
17,540
-51.3%
0.21%
-47.0%
Q4 2017$2,328,000
-0.8%
36,009
-3.7%
0.40%
-10.8%
Q3 2017$2,346,000
+0.3%
37,399
-3.2%
0.44%
+23.7%
Q2 2017$2,340,000
+18.5%
38,645
+1.5%
0.36%
+16.6%
Q1 2017$1,974,000
+26.1%
38,070
+7.9%
0.31%
+11.6%
Q4 2016$1,565,000
+6.9%
35,294
+14.7%
0.28%
+1.8%
Q3 2016$1,464,00030,7640.27%
Other shareholders
BAXTER INTL INC shareholders Q3 2019
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders